Welcome to our dedicated page for VICTORY SQUARE TECH ORD news (Ticker: VSQTF), a resource for investors and traders seeking the latest updates and insights on VICTORY SQUARE TECH ORD stock.
Victory Square Technologies Inc. reports portfolio and capital-allocation developments for a venture builder focused on healthcare infrastructure, digital health, artificial intelligence and emerging technology platforms. Recurring updates cover operating and financial results, platform scaling, normal course issuer bid activity and the progress of portfolio companies.
Company news frequently centers on Hydreight and VSDHOne, including compliant patient access, prescribing, pharmacy fulfillment and healthcare delivery across categories such as GLP-1 therapies, peptides, hormone optimization, diagnostics and wellness programs. Other portfolio themes include Insu Therapeutics' peptide delivery work and Pawsible Ventures' activity in pet wellness, AI and health technology.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Victory Square Technologies announced its participation in the Planet MicroCap Showcase: VEGAS 2023 on April 26, 2023, at 9:30 AM PST. CEO Shafin Diamond Tejani will present and answer audience queries.
The event will be accessible via a live webcast. Interested investors can schedule 1x1 meetings at the conference venue in Las Vegas. Victory Square's portfolio includes over 25 disruptive tech companies across sectors such as digital health, AI, VR/AR, and blockchain. The company reports a net asset value of $80M and approximately $6.8M in cash and liquid securities, indicating strong financial health with over 24 months of runway.
Victory Square Technologies Inc. (OTC: VSQTF) announced that its portfolio company, Hydreight Technologies Inc., has received final approval for its qualifying transaction and commenced trading on the TSX Venture Exchange under the symbol 'NURS' on December 1, 2022. Hydreight achieved a remarkable 606% year-over-year growth in new business partners, totaling approximately 537 in 2022. VST will own about 73.72% of Hydreight's outstanding shares, enhancing its position in the wellness services sector, which offers mobile health solutions across the U.S.
Victory Square Technologies reported a 2022 Q3 unaudited Net Asset Value (NAV) of $80,701,078 as of September 30, 2022. Revenue surged, with Q3 2022 figures at $1,620,221 compared to $337,761 in Q3 2021, and $3,852,101 for the nine months in 2022 versus $748,835 in 2021. Gross margin improved to 56% for Q3 and 55% for the nine-month period. The company anticipates trading of shares under the symbol NURS post-Qualifying Transaction of IV Hydreight on December 1, 2022. CEO Shafin Diamond Tejani highlighted a strong balance sheet and ongoing growth in digital health assets.
Victory Square Technologies has reported an unaudited Net Asset Value (NAV) of $80,701,078 as of September 30, 2022. The company has changed its auditor to MNP LLP, enhancing its advisory capabilities. Notable portfolio highlights include significant growth in Digital Health assets, especially IV Hydreight, which has seen approximately 606% year-over-year growth in new business partner sign-ups. The company has featured in prominent publications such as Forbes and Newsweek. An investor Q&A webinar is scheduled for November 15, 2022.
Victory Square Technologies (OTC:VSQTF) announced the appointment of MNP LLP as its new auditor on October 13, 2022, replacing Dale Matheson Carr-Hilton Labonte, LLP. The board of directors confirmed that no reportable events occurred with the former auditor. Both auditors have agreed with the information provided in the Notice of Change. This transition aims to maintain transparency and uphold high standards in financial reporting. Victory Square continues its commitment to supporting startups in tech sectors, enhancing growth opportunities for its portfolio companies.